Exela Technologies (XELA) Stock Forecast, Price & News

Exela Technologies (NASDAQ:XELA) Frequently Asked Questions

Is Exela Technologies a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exela Technologies in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Exela Technologies stock.
View analyst ratings for Exela Technologies or view top-rated stocks.

Are investors shorting Exela Technologies?

Exela Technologies saw a increase in short interest in April. As of April 30th, there was short interest totaling 40,450,000 shares, an increase of 44.9% from the April 15th total of 27,920,000 shares. Based on an average daily volume of 36,020,000 shares, the short-interest ratio is presently 1.1 days.
View Exela Technologies' Short Interest.

When is Exela Technologies' next earnings date?

Exela Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, August 9th 2022.
View our earnings forecast for Exela Technologies.

How were Exela Technologies' earnings last quarter?

Exela Technologies, Inc. (NASDAQ:XELA) posted its earnings results on Tuesday, May, 10th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.10) by $0.07. During the same period in the prior year, the business posted ($0.76) earnings per share.
View Exela Technologies' earnings history.

When did Exela Technologies' stock split? How did Exela Technologies' stock split work?

Exela Technologies's stock reverse split on Tuesday, January 26th 2021. The 1-3 reverse split was announced on Monday, January 25th 2021. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 25th 2021. An investor that had 100 shares of Exela Technologies stock prior to the reverse split would have 33 shares after the split.

What price target have analysts set for XELA?

2 brokers have issued 1-year price targets for Exela Technologies' shares. Their forecasts range from $0.55 to $2.00. On average, they expect Exela Technologies' share price to reach $1.28 in the next year. This suggests a possible upside of 370.8% from the stock's current price.
View analysts' price targets for Exela Technologies or view top-rated stocks among Wall Street analysts.

Who are Exela Technologies' key executives?

Exela Technologies' management team includes the following people:

• Suresh Yannamani, President (Age 51)
• Ronald Clark Cogburn, Chief Executive Officer, Director (Age 61)
• Jim Reynolds, Chief Financial Officer, Director (Age 48)
• Mark Fairchild, President, Exela Enterprise Solutions (Age 57) (LinkedIn Profile)
• Shrikant Sortur, Executive Vice President - Global Finance (Age 44) (LinkedIn Profile)
• Joshua M. Black, Director (Age 30)
• Par Chadha, Director (Age 62) (LinkedIn Profile)
• Gordon J. Coburn, Director (Age 53)
• Nathaniel J. Lipman, Director (Age 53)
• Matthew H. Nord, Director (Age 38)

What is Ron Cogburn's approval rating as Exela Technologies' CEO?

140 employees have rated Exela Technologies CEO Ron Cogburn on Glassdoor.com. Ron Cogburn has an approval rating of 46% among Exela Technologies' employees. This puts Ron Cogburn in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Exela Technologies' key competitors?

Some companies that are related to Exela Technologies include Capita (CTAGY), Rimini Street (RMNI), Limelight Networks (LLNW), OptimizeRx (OPRX), Liquidity Services (LQDT), Cass Information Systems (CASS), Chykingyoung Investment Development (CHYI), Accolade (ACCD), Nutex Health (NUTX), Priority Technology (PRTH), Points.com (PCOM), DHI Group (DHX), Loyalty Ventures (LYLT), PFSweb (PFSW) and ICTS International (ICTSF).
View all of XELA's competitors.

What other stocks do shareholders of Exela Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exela Technologies investors own include Biocept (BIOC), Acasti Pharma (ACST), Avinger (AVGR), Bionano Genomics (BNGO), Heat Biologics (HTBX), T2 Biosystems (TTOO), Onconova Therapeutics (ONTX), Outlook Therapeutics (OTLK), (SCON) and AgEagle Aerial Systems (UAVS).

What is Exela Technologies' stock symbol?

Exela Technologies trades on the NASDAQ under the ticker symbol "XELA."

Who are Exela Technologies' major shareholders?

Exela Technologies' stock is owned by a variety of institutional and retail investors. Top institutional investors include B. Riley Financial Inc. (7.31%), B. Riley Asset Management LLC (2.48%), Vanguard Group Inc. (2.12%), BlackRock Inc. (1.00%), Shay Capital LLC (0.72%) and Invesco Ltd. (0.24%). Company insiders that own Exela Technologies stock include Marc A Beilinson, Mark D Fairchild, Par Chadha, Shrikant Sortur and William L Transier.
View institutional ownership trends for Exela Technologies.

Which major investors are selling Exela Technologies stock?

XELA stock was sold by a variety of institutional investors in the last quarter, including Jane Street Group LLC, Group One Trading L.P., Cutler Group LP, Simplex Trading LLC, and National Asset Management Inc..
View insider buying and selling activity for Exela Technologies or view top insider-selling stocks.

Which major investors are buying Exela Technologies stock?

XELA stock was acquired by a variety of institutional investors in the last quarter, including B. Riley Financial Inc., B. Riley Asset Management LLC, Vanguard Group Inc., BlackRock Inc., Shay Capital LLC, Invesco Ltd., JPMorgan Chase & Co., and State Street Corp. Company insiders that have bought Exela Technologies stock in the last two years include Marc A Beilinson, Mark D Fairchild, Shrikant Sortur, and William L Transier.
View insider buying and selling activity for Exela Technologies or or view top insider-buying stocks.

How do I buy shares of Exela Technologies?

Shares of XELA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Exela Technologies' stock price today?

One share of XELA stock can currently be purchased for approximately $0.27.

How much money does Exela Technologies make?

Exela Technologies has a market capitalization of $131.22 million and generates $1.17 billion in revenue each year. The company earns $-142.39 million in net income (profit) each year or ($0.990010) on an earnings per share basis.

How many employees does Exela Technologies have?

Exela Technologies employs 17,000 workers across the globe.

What is Exela Technologies' official website?

The official website for Exela Technologies is www.exelatech.com.

How can I contact Exela Technologies?

Exela Technologies' mailing address is 2701 EAST GRAUWYLER ROAD, IRVING TX, 75061. The company can be reached via phone at 844-935-2832 or via email at [email protected].